Table I.

Hematologic features of myelodysplastic syndrome patients of whom bone marrow mesenchymal stroma cells were obtained.

UPN	Age (Year)	M/F	Dx (WHO)	Date of material obtained	Transition to acute leukemia	Outcome	IPSS	IPSS-R	WBC	Neutrophils	Hb	Plt	PB-blasts (%)	BM-blasts (%)	Karyotype
33	51	M	MDS-SLD	2014/10/10	No	Alive	Int-1	Int	5200	4030	7.6	135	0	0.8	complex
54	58	F	MDS-EB1	2014/12/16	No	Alive	Int-1	Int	2400	1080	9.3	74	0	5.6	46,XX
59	55	M	MDS-MLD	2015/1/27	No	Alive	Low	Very low	4700	2961	13.7	56	0	0	46,XY
82	78	M	MDS-MLD	2015/4/30	No	Unknown	Int-1	Very low	1900	1267	10.6	57	0	2	45,X,-Y
95	68	M	MDS-SLD	2015/8/20	No	Unknown	Low	Low	10200	7905	12.1	18	0	1.2	46,XY
93	82	M	MDS-SLD	2015/8/11	No	Dead	Low	Very low	2200	1606	10.4	105	0	0	46,XY,del (20)(q11)
101	77	M	MDS-U based on defining cytogenetic abnormality	2015/9/17	No	Alive	Low	Very low	4600	2852	10	30	0	0	45,X,-Y
102	47	F	MDS-MLD	2015/9/30	No	Alive	Int-1	Low	2800	1274	8.3	15	0	0	46,XX
103	22	M	MDS-MLD	2015/10/9	No	Unknown	Low	Int	2600	845	6.3	21	0	0	46,XY
107	82	F	MDS-MLD	2015/10/22	No	Alive	Low	Low	6100	4148	11.2	187	0.5	0.4	47,XX,+8
64_2	46	F	MDS-MLD	2016/3/8	No	Alive	Low	Very low	4500	2835	13.1	299	0	2	46,XX
141	84	M	MDS with isolated del(5q)	2016/5/19	No	Alive	Int-1	Int	3500	1295	9.5	344	0	0.5	46,XY,del(5q)
115	50	M	MDS-MLD	2016/10/11	No	Unknown	Int-1	Low	6600	5214	4.3	42	0.5	2	46,XY, del(11)(q14)
8	72	M	MDS-EB1	2014/8/8	No	Unknown	Int-1	High	1700	408	9	78	0	5.2	46,XY
12	38	M	MDS-EB2	2014/8/26	No	Unknown	Int-2	High	3000	1410	10.3	95	0.5	10	45,XY,-7
58	71	M	MDS-EB1	2015/1/22	No	Unknown	Int-2	Very high	2900	2233	8.3	31	0	9.2	complex
22	66	M	MDS-EB1	2014/11/27	Yes	Unknown	Int-1	High	2000	910	7.6	16	0	7.6	46,XY
44	72	M	MDS-EB2	2015/1/22	Yes	Dead	High	Very high	16300	2853	9.1	97	5	16.8	46,XY,-7,+m/46, XY,idem,del(12) (p13)
38	56	M	MDS-EB2	2014/10/14	No	Dead	Int-2	High	5500	4895	8.3	164	0	12.4	46,XY
120	68	F	MDS-EB2	2016/3/10	Yes	Dead	High	Very high	1100	374	7.8	19	0	17.2	complex
108	87	M	MDS-U with > 1% PB blasts	2015/10/26	No	Dead	in-2	High	11400	10864	8.1	65	1.5	4.8	46,XY,del(20) (q11)/46,XY, idem,-7,+8
175	68	M	MDS-EB1	2016/2/3	Yes	Dead	Int-2	High	2000	1110	8.8	30	2	4.4	complex
4	77	M	AML with MRC	2014/4/2		Dead			4500	393	8.9	23	17	49.5	complex
30	72	M	AML with MRC	2014/10/8		Unknown			800	248	7.7	50	2	21	45,X,-Y
13	61	M	AML (M6A) with MRC	2014/9/10		Dead			1300	338	7.6	17	12	12.8	complex
18	67	F	AML with MRC	2014/9/16		Dead			2000	520	7.9	7	2.5	66	45,XX,-7
127	64	M	AML with MRC	2016/4/11		Alive			1300	240	9.3	78	0	23.2	46,XY
133	67	F	AML with MRC	2016/4/26		Dead			1400	400	7.3	25	8	34	45,XX,-18
98	42	F	AML with MRC	2015/9/9		Dead			2000	270	11.3	175	1.5	21	46,XX,inv(16) (p13;q22)/47, XX,idem+22

UPN, unique patient number; M/F, male/female; Dx, diagnosis; IPSS, International Prognostic Scoring System; IPSS-R, revised IPSS; WBC, while blood cell count (×10⁹/l); Hb, hemoglobin g/dl; Plt, platelets (×10¹²/l); PB, peripheral blood; BM, bone marrow; MDS, myelodysplastic syndrome; AML with MRC, acute myeloid leukemia with myelodysplasia-related changes; Unknown, due to transfer to another hospital.